Transforming growth factor betal

Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor betal gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996 271(30) 17779-17784. [Pg.314]

Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T (1998) Transforming growth factor-betal increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 252 747-752... [Pg.195]

Aiba, S. et al, In vitro treatment of human transforming growth factor-betal-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction, Immunology, 101, 68, 2000. [Pg.78]

Vidigal, P. G., Germer, J. J., and Zein, N. N., Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-betal genes in chronic hepatitis C patients treated with interferon and ribavirin, J. Hepatol., 36, 271, 2002. [Pg.93]

Wu, L. et al., Transforming growth factor-betal genotype and susceptibility to chronic obstructive pulmonary disease, Thorax, 59, 126, 2004. [Pg.95]

Kwak HJ, Park MJ, Cho H, Park CM, Moon SI, Lee HC, Park IC, Kim MS, Rhee CH, Hong SI. 2006. Transforming growth factor-betal induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Spl in human fibrosarcoma cells. Mol Cancer Res 4 209-220. [Pg.391]

Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG. 2003. Transforming growth factor-betal activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22 4314-4332. [Pg.393]

Sharma K, Eltayeb BO, McGowan TA, Dunn SR, Alzahabi B, Rohde R, Ziyadeh FN, Lewis EJ. Captopril-induced reduction of serum levels of transforming growth factor-betal correlates with long-term renoprotection in insulin-dependent diabetic patients. American Journal of Kidney Diseases 1999, 34, 818-823. [Pg.85]

Transforming growth factor betal induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273 29195-29201. [Pg.262]

Chang, N.S., Transforming growth factor-betal blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts, BMC Cell Biol., 3, 8, 2002. [Pg.272]

L2. Lamm, M. L., Sintich, S. M., and Lee, C., A proliferative effect of transforming growth factor-betal on a human prostate cancer cell line, TSU-Prl. Endocrinology 139, 787-790 (1998). [Pg.150]

FI 1. Fried, G., and Wramsby, H., Increase in transforming growth factor betal in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy. Hum. Reprod. 13, 656-659 (1998). [Pg.323]

Blennow, K. (2004). Increased cerebrospinal fluid levels of transforming growth factor-betal in Alzheimer s disease. Neurosci. Lett. 367,194-196. [Pg.278]

Basu A, Krady JK, Enterline JR, Levison SW (2002) Transforming growth factor betal prevents IL-1 beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. Glia 40 109-120. [Pg.627]

Mumper, R.J. Hoffman, A.S. Puolakkainen, P.A. Bouchard, L.S. Gombotz, W.R. Calcium-alginate beads for the oral delivery of transforming growth factor-betal (TGF-Betal) stabilization of TGF-betal by the addition of polyacrylic acid within acid-treated beads. J. Controlled Release 1994, 30, 241-251. [Pg.1655]

Waiser J, Dell K, Kreutzkamp J, BohlerT, Budde K, Peters FI, and Neumayer FIFI. FK506, transforming growth factor-betal and mesangial matrix synthesis parallels and differences compared with cyclosporine A. Cytokine 33 59-65,2006. [Pg.243]

Li C, Urn SW, Choi BS, Lee SH, Cha JH, Kim iS, Kim J, Yang CW. inhibitory effect of pravastatin on transforming growth factor betal-inducibie gene h3 expression in a rat modei of chronic cyciosporine nephropathy. Am J Nephroi 2005 25 611-620. [Pg.669]

Shihab FS, Bennett WM,Yi H, Choi SO, AndohTF. Siroiimus increases transforming growth factor-betal expression and potentiates chronic cyciosporine nephrotoxicity. Kidney int 2004 65 1262-1271. [Pg.676]

Jimenez SA, Artlett CM, Sandorfi N, Derk C, Eatinis K, Sawaya H, Haddad R, Shanahan JC Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy) Study of inflammatory cells and transforming growth factor betal expression in affected skin. Arthritis Rheum 50 2660-2666, 2004. [Pg.722]

Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN. Transcriptional activation of transforming growth factor-betal in mesangial cell culture by high glucose concentration. Kidney Int 1998 54 1107-16. [Pg.1734]

Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnilc BR, et al. Increased renal production of transforming growth factor-betal in patients with type II diabetes. Diabetes 1997 46 854-9. [Pg.1741]

Zanetti D, Poh G, Vizio B, Zingaro B, Chiarpotto E, Biasi E. 4-hydroxynonenal and transforming growth factor-betal expression in colon cancer. Mol Aspects Med 2003 Aug-Oct 24(4-5) 273-280. [Pg.86]

Lake, B. G., Rumsby, P. C., Price, R. J., and Cunninghame, M. E. (2000). Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-betal gene expression in the rat, Syrian hamster and guinea pig. Mutat Res 448, 213-225. [Pg.474]

Wikstrom P, Bergh A, Dumber JE. Transforming growth factor-betal and prostate cancer. Scand J Urol Nephrol. 2000 34 85. [Pg.653]

Wikstrom P, Dumber J, Bergh A. Role of transforming growth factor-betal in prostate cancer. Microsc Res Tech.2001 52 411. [Pg.653]

Oberhammer FA, Qin H (1995) Effect of three tumor promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-betal. Carcinogenesis 16 1363-1371... [Pg.149]

Sanderson M, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS (1995) Hepatic expression of mature transforming growth factor betal in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92 2572-2576... [Pg.151]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...